Chronic myeloid leukemia (CML) is a type of cancer that affects blood-forming tissues. With appropriate treatment, it is possible for people with CML to experience remission. In the 1970s, the 5-year ...
Imatinib mesylate (IM) was approved in 2001 for the treatment of patients with CML who failed IFN-α therapy 1 and was subsequently established as first-line therapy for CML. Consequently, the annual ...
Buy shares in a company that's had no permanent CEO for more than six months? Doesn't seem like such a good idea, at first glance. Except, perhaps, in the case of CML HealthCare Inc., a Mississauga ...
As introduced in preceding reviews in this issue, chronic myelogenous leukemia (CML) is a malignant disease resulting from the neoplastic transformation of an hematopoietic stem cell (HSC). CML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback